<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019044</url>
  </required_header>
  <id_info>
    <org_study_id>ORVACS 009</org_study_id>
    <nct_id>NCT01019044</nct_id>
  </id_info>
  <brief_title>Exploration of HIV Reservoirs</brief_title>
  <acronym>MUCOVIR</acronym>
  <official_title>Virologic and Immunologic Evaluation of the Deep Viral Reservoirs in HIV-1 Infected Patients With Long Term Viral Suppression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Objectif Recherche Vaccins SIDA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Objectif Recherche Vaccins SIDA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective study in HIV-1 infected patients with a plasma viral load below the limit of
      detection and stable for at least 5 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the mucosal HIV reservoirs (HIV-DNA quantification and distribution of the
      infected T lymphocytes in the gut mucosa associated lymphoid tissue compared to the blood in
      HIV-1 infected patients under antiretroviral treatment with an undetectable plasma viral load
      below the 50 copies/ml limit of detection for at least 5 years).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of the HIV-RNA plasma viral load using ultrasensible assay (limit of detection: 1 copy/ml)</measure>
    <time_frame>Single patient visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of the HIV proviral DNA in the rectal mucosa biopsies and in the PPBMCs</measure>
    <time_frame>Single patient visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative, phenotypic and functional description of the long-term immune reconstitution in the rectal mucosa biopsies</measure>
    <time_frame>Single patient visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantification of HIV proviral DNA in the total CD4 lymphocytes</measure>
    <time_frame>Single patient visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetics of the antiretroviral molecules in the rectal mucosa biopsies and in the blood</measure>
    <time_frame>Single patient visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">11</enrollment>
  <condition>HIV-1 Infection</condition>
  <arm_group>
    <arm_group_label>Rectal mucosa biopsy</arm_group_label>
    <description>Rectal mucosa samples collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rectal mucosa biopsy</intervention_name>
    <description>Collection of a maximum of 15 rectal mucosa samples in the high portion of the rectum near the rectosigmoidal junction</description>
    <arm_group_label>Rectal mucosa biopsy</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and total blood samples A maximum of 15 rectal mucosa biopsy samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-1 infected patients followed in specialized infectious disease/HIV hospital department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV-1 documented infection

          -  HIV-1 plasma viral load measurable before antiretroviral treatment initiation

          -  Patients treated with an antiretroviral combination containing a protease inhibitor
             and/or a non-nucleosidic reverse transcriptase inhibitor without any interruption
             since treatment initiation

          -  Patients with a stable plasma viral load below the limit of detection (HIV-RNA &lt; 50
             copies/ml since January 2006 and/or HIV-RNA &lt; 200 copies/ml during the anterior
             period) under antiretroviral treatment for at least 5 years and for at least 90 % of
             the measures

        Exclusion Criteria:

          -  Contraindication to the biopsy

          -  No ability or willingness to provide informed consent

          -  Concomitant treatment with antithrombotics or platelets antiaggregatory

          -  Patients co-infected with HCV and or HBV

          -  Patients who received an immunosuppressive treatment during 3 months prior enrollment
             (chemotherapy, radiotherapy, corticotherapy, splenectomy) or an immunotherapy during 5
             years prior enrolment (IL-2, anti-HIV vaccine, IFN-alpha)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine KATLAMA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Pitié-Salpêtrière</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François LECARDONNEL, MSc</last_name>
    <role>Study Director</role>
    <affiliation>ORVACS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G; DECAMUNE and ORVACS Study Groups. Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients. J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):255-9. doi: 10.1097/QAI.0b013e318282537f.</citation>
    <PMID>23274932</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>February 12, 2013</last_update_submitted>
  <last_update_submitted_qc>February 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Viral reservoirs</keyword>
  <keyword>Viral load</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

